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Cardiovascular disease (CVD) is the leading cause 
of death worldwide. Approximately 80% of all 
cardiovascular-related deaths occur in low- to middle-
income countries and at a younger age compared 
with high-income countries.[1] The economic burden 
imposed by CVD on developing countries in terms of 
loss of productive years of life and amount of fiscal resources spent on 
secondary and tertiary care is considerably high.
A sizeable proportion of the population-attributable risk for 
myocardial infarction is accounted for by nine modifiable risk 
factors, regardless of the geographical region.[2] Heart failure is an 
important cause of morbidity and mortality in sub-Saharan Africa 
(SSA) and the spectrum of aetiology in this region is different from 
that in many high-income countries.[3,4]
In Africa, there are major concerns with regard to the success of 
strategies for primary and secondary prevention of CVD.[1] Challenges 
include lack of epidemiological and outcome data, limited national 
resources, poor political will and motivation, suboptimal healthcare 
infrastructure, low numbers of appropriately skilled healthcare 
personnel and lack of prediction models in many populations. Sadly, 
available data suggest that CVD is poorly managed in SSA.[5,6] 
This issue of CME focuses on the clinical approaches to common 
cardiovascular challenges. It forms the third part of a series of 
articles jointly produced by South African (SA) cardiologists and 
family physicians with the dual objectives of empowering doctors 
who manage these conditions in primary care settings in SA 
and improving the care of CVD patients in such settings and 
emergency departments. In the first issue, heart failure,[7] dyspnoea,[8] 
hypertension in the young[9] and valvular heart disease[10] were 
reviewed. In the second issue, the important clinical problems of 
infective endocarditis[11] and pericardial disease[12] were discussed. 
The current edition provides an evidence-based and pragmatic 
approach to acute coronary syndromes and chest pain,[13] and 
suspected tachyarrhythmias in the emergency room.[14]
Pandie et al.[13] discuss the approach to chest pain and acute 
myocardial infarction. The history and physical examination are the 
mainstay of clinical assessment, and are complemented by a 12-lead 
electrocardiogram (ECG) and cardiac biomarkers for correct diagnosis. 
Chest pain is a common presentation at emergency rooms. The first 
priority should always be to ensure rapid and accurate diagnosis 
of serious acute chest pain syndromes, including acute coronary 
syndromes (ACSs), aortic dissection, pulmonary embolism, cardiac 
tamponade, tension pneumothorax, and acute abdominal syndromes.
Elevated serum cardiac biomarkers provide evidence of myocardial 
cell injury. While the ECG is a crucial investigative tool, unfortunately 
many primary and secondary hospitals in SA and throughout SSA lack 
this equipment (or, if present, have no ECG strips, and the machines 
are not calibrated regularly). Despite these shortcomings, the authors 
present what should be the standard approach to chest pain and acute 
myocardial infarction. For example, the Marburg Heart Score, which 
has an excellent negative predictive value, can be used at a primary care 
level in the absence of a functional ECG machine. 
A systematic approach to the evidence-based management of ACSs 
is discussed. The management of ST elevation myocardial infarction 
(STEMI) patients includes providing the fastest and safest method 
of reperfusion therapy available – primary percutaneous coronary 
intervention or fibrinolysis, while initiating essential adjunctive therapies 
(antiplatelet therapy – aspirin with P2Y12 inhibitors, anti coagulation 
heparin or low-molecular-weight heparin), and cardiac monitoring.
In the emergency or primary healthcare setting, patients often 
present with tachycardia or a history of palpitations, which may lead 
the doctor to suspect an underlying tachycardia. Chin et al.[14] review 
the mechanisms, diagnostic evaluation and management of tachycardia. 
A narrow complex tachycardia or supraventricular tachycardia 
usually has a QRS duration of <120 ms, unless there is bundle branch 
block or an intraventricular conduction abnormality. Supraventri-
cular tachycardia comprises a wide range of arrhyth mias that have 
their origin above the bifurcation of the bundle of His, encompassing 
sinus tachycardia, atrial flutter, atrial fibrillation, atrial tachycardia, 
atrioventricular junctional re-entrant tachycardia, including atrio-
ventricular nodal re-entrant tachycardia, atrioventricular re-entrant 
tachycardia and junctional ectopic tachycardia. 
A wide complex tachycardia has a QRS duration ≥120 ms and 
may be caused by one of the following mechanisms: (i) ventricular 
tachycardia, which must be the default diagnosis in any patient with 
a wide complex tachycardia; (ii) supraventricular tachycardia with a 
right or left bundle branch block or an intraventricular conduction 
abnormality; (iii) pre-excited tachycardia (Wolff-Parkin son-White 
syndrome) over an accessory pathway; and (iv) pacemaker tachy-
cardia. 
A complete history should cover the heart rate and regularity, 
mode of onset and termination, precipitating factors, associated 
symptoms, and any associated heart disease. The ECG is the 
hallmark of diagnosis. One may classify tachycardia into narrow 
(supraventricular) tachycardia and wide complex tachycardia, which 
may be regular or irregular, and the differential diagnosis of each of 
these categories should be considered. 
It is our sincere hope that this series of articles on common 
cardiovascular conditions often encountered in primary care settings 
in SA and SSA will improve the care of patients with CVD. 
Furthermore, it is our wish that the articles clearly emphasise 




Department of Family Medicine and
Primary Health Care, Sefako Makgatho Health 
Sciences University, Pretoria, South Africa
profbanjo@gmail.com
Ntobeko A B Ntusi 
Guest editor 
Division of Cardiology, Department of Medicine, 
Faculty of Health Sciences, University of 
Cape Town and Groote Schuur Hospital, 
Cape Town, South Africa
ntobeko.ntusi@gmail.com
GUEST EDITORIAL
Cardiovascular medicine in primary healthcare in 
sub-Saharan Africa: Minimum standards for practice (part 3)
CME
CME
238       March 2016, Vol. 106, No. 3
1. Gersh BJ, Sliwa K, Mayosi BM, Yusuf S. The epidemic of cardiovascular disease in the developing world: 
Global implications. Eur Heart J 2010;31:642-648. [http://dx.doi.org/10.1093/eurheartjehq030]
2. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with 
myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 
2004;364(9438):937-952.
3. Ntusi NAB, Mayosi BM. Epidemiology of heart failure in sub-Saharan Africa. Expert Rev Cardiovasc 
Ther 2009;7:169-180. [http://dx.doi.org/10.1586/14779072.7.2.169] 
4. Damasceno A, Mayosi BM, Sani M, et al. The causes, treatment, and outcome of acute heart failure in 
1006 Africans from 9 countries. Arch Intern Med 2012;172(18):1386-1394.
5. Steyn K. Heart Disease in South Africa. Cape Town: Medical Research Council: The Heart and 
Stroke Foundation of South Africa, 2007. http://www.mrc.ac.za/chronic/heartandstroke.pdf (accessed 6 
December 2015).
6. Ntusi NAB. Dismal management of hypertension at primary level: Does it reflect a failure of patients, a 
failure of the system or a failure of doctors? Cardiovasc J Afr 2011;22(4):172-174.
7. Kraus S, Ogunbanjo G, Sliwa K, Ntusi NAB. Heart failure in sub-Saharan Africa: A clinical approach. S 
Afr Med J 2016;106(1):23-31. [http://dx.doi.org/10.7196/SAMJ.2016.v106i1.10325] 
8. Coccia CBI, Palkowski GH, Schweitzer B, Motsohi T, Ntusi NAB. Dyspnoea: Pathophysiology and a 
clinical approach. S Afr Med J 2016;106(1):32-36. [http://dx.doi.org/10.7196/SAMJ.2016.v106i1.10324] 
9. Mangena P, Saban S, Hlabyago KE, Rayner B. An approach to the young hypertensive patient. S Afr 
Med J 2016;106(1):36-38. [http://dx.doi.org/10.7196/SAMJ.2016.v106i1.10329] 
10. Cupido BJ, Peters F, Ntusi NAB. An approach to the diagnosis and management of valvular heart 
disease. S Afr Med J 2016;106(1):39-42. [http://dx.doi.org/10.7196/SAMJ.2016.v106i1.10326] 
11. Hitzeroth J, Beckett N, Ntuli P. An approach to the patient with infective endocarditis. S Afr Med J 
2016;106(2):145-150. [http://dx.doi.org/10.7196/SAMJ.2016.v106i2.10327] 
12. Kyriakakis CG, Mayosi BM, de Vries E, Isaacs A, Doubell AF. An approach to the patient with 
suspected pericardial disease. S Afr Med J 2016;106(2):151-155. [http://dx.doi.org/10.7196/SAMJ.2016.
v106i2.10328] 
13. Pandie S, Hellenberg D, Hellig F, Ntsekhe M. An approach to chest pain and acute myocardial 
infarction. S Afr Med J 2016;106(3):239-245. [http://dx.doi.org/10.7196/SAMJ.2016.v106i3.10323] 
14. Chin A, Vezi B, Namane M, Weich H, Scott-Millar R. An approach to the patient with suspected 
tachycardia in the emergency department. S Afr Med J 2016;106(3):246-250. [http://dx.doi.
org/10.7196/SAMJ.2016.v106i3.10322] 
S Afr Med J 2016;106(3):237-238. DOI:10.7196/SAMJ.2016.v106i3.10593
